# Supermicrosurgical Lymphaticovenous Anastomosis for Prevention of Upper Limb Lymphedema

> **NCT07026292** · NA · NOT_YET_RECRUITING · sponsor: **Tianjin Medical University Cancer Institute and Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Breast Cancer-Related Lymphedema
- Lymphedema
- Breast Cancer Invasive

## Interventions

- **PROCEDURE:** Immediate Distal Lymphaticovenous Anastomosis (ID-LVA)

## Key facts

- **NCT ID:** NCT07026292
- **Lead sponsor:** Tianjin Medical University Cancer Institute and Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07-01
- **Primary completion:** 2027-05-31
- **Final completion:** 2029-05-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07026292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07026292, "Supermicrosurgical Lymphaticovenous Anastomosis for Prevention of Upper Limb Lymphedema". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT07026292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*